Multiple Sclerosis Clinical Trial

The Multiple Sclerosis Continuous Quality Improvement (MSCQI) Collaborative

Summary

To establish the first systems level continuous quality improvement (CQI) collaborative for multiple sclerosis (MS) in the United States, to conduct benchmarking analyses and assessments of geographic variation in MS care quality and value, and study the effect of CQI interventions on improvement of selected performance (quality) indicators.

View Full Description

Full Description

This is a three year study which employed a step-wedge randomized design which exposed three of four participating centers to a healthcare QI intervention during the 3 year period. Each of the centers exposed to an intervention served as its own control during a baseline pre-intervention period during the first year of the study. The fourth site served as a longitudinal control for comparison to the other three centers exposed to a QI intervention.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Adults aged 18 years or older with documented clinically confirmed MS who are followed by one of the participating MS centers.

Exclusion Criteria:

Candidates will be excluded from study entry if they are unable or unwilling to provide informed consent.

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

694

Study ID:

NCT03480854

Recruitment Status:

Completed

Sponsor:

Dartmouth-Hitchcock Medical Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 4 Locations for this study

See Locations Near You

Neurology Associates of Greater Orlando
Maitland Florida, 32751, United States
Massachusetts General Hospital Multiple Sclerosis Center
Boston Massachusetts, 02114, United States
Concord Hospital
Concord New Hampshire, 03301, United States
University of Vermont Multiple Sclerosis Center
Burlington Vermont, 05401, United States

How clear is this clinincal trial information?

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

694

Study ID:

NCT03480854

Recruitment Status:

Completed

Sponsor:


Dartmouth-Hitchcock Medical Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider